Document ID: chunk:federal_register_of_legislation:F2022L01398:reg:9:p3
Version: federal_register_of_legislation:F2022L01398
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 10071–11518

legs syndrome;
Note: being obese is defined in the Schedule 1 – Dictionary.
(30)      having narcolepsy or obstructive sleep apnoea at the time of the clinical worsening of restless legs syndrome;
(31)      being pregnant at the time of the clinical worsening of restless legs syndrome;
(32)      inability to undertake physical activity greater than 3 METs for a continuous period of at least the 1 year before the clinical worsening of restless legs syndrome;
Note: MET is defined in the Schedule 1 – Dictionary.
(33)      having dyslipidaemia for at least the 1 year before the clinical worsening of restless legs syndrome;
Note: dyslipidaemia is defined in the Schedule 1 – Dictionary.
(34)      having migraine at the time of the clinical worsening of restless legs syndrome;
(35)      having chronic obstructive pulmonary disease or asthma at the time of the clinical worsening  of restless legs syndrome;
(36)      having a cerebrovascular accident within the 3 months before the clinical worsening of restless legs syndrome;
(37)      for restless legs syndrome augmentation only, taking a dopaminergic agent including levodopa and pramipexole, or tramadol, for a continuous period of at least the 3 months before that clinical worsening of restless legs syndrome;
Note: restless legs syndrome augmentation is defined in the Schedule 1 – Dictionary.
(38)      inability to obtain appropriate clinical management for restless legs syndrome.